![Favorite pages[Japanese page]](/files/000137013.png){kind=small}
](/files/000137010.png){kind=small}
Here begins the text.
Pmda Pharmaceuticals and Medical Devices Agency
What's newBack number
December 8, 2022The 4th ICH Efficacy Forum: ICH Efficacy Guideline Update
- December 7, 2022JP Drafts (December 2022) posted
- December 5, 2022Revisions of PRECAUTIONS: Amlodipine besilate, etc. posted
- December 2, 2022PMDA Risk Communication: Clopidogrel sulfate, etc. posted
- December 1, 2022PDG (Pharmacopoeial Discussion Group) Stage 2 Drafts (December, 2022) posted
- December 1, 2022PMDA-ATC E-learning videos are now available on YouTube
- November 30, 2022English Translation of Review Report: Comirnaty RTU (bivalent, Original/Omicron BA.1) and Spikevax (bivalent, Original/Omicron BA.1)
- November 30, 2022The 2nd Subcommittee on Software as a Medical Device Utilizing AI and Machine Learning
- November 29, 2022PMDA Updates (November, 2022) posted
- December 5, 2022Revisions of PRECAUTIONS: Amlodipine besilate, etc. posted
- December 2, 2022PMDA Risk Communication: Clopidogrel sulfate, etc. posted
- Currently, there is no applicable information.
- December 7, 2022JP Drafts (December 2022) posted
- December 1, 2022PDG (Pharmacopoeial Discussion Group) Stage 2 Drafts (December, 2022) posted
- November 30, 2022The 2nd Subcommittee on Software as a Medical Device Utilizing AI and Machine Learning
- December 1, 2022PMDA-ATC E-learning videos are now available on YouTube
- November 29, 2022PMDA Updates (November, 2022) posted
